Insights

Global Leadership Sebia's strong position in the international IVD market, demonstrated by recent expansion in the United States and recognition as a top emerging MedTech company in India, indicates a growing demand for its advanced diagnostic solutions across key markets.

Innovative Product Pipeline The company's ongoing development of specialized tests for multiple myeloma, including serum-based MRD and anti-MCV antibody tests, creates opportunities to introduce new diagnostic tools and expand market share in hematology and oncology segments.

Market Expansion Opportunities Sebia's strategic partnerships, such as with Janssen Biotech, and participation in prominent industry awards suggest a focus on increasing product adoption, which can be leveraged to upsell complementary diagnostics and automated laboratory solutions.

Technological Edge Utilization of advanced tech like Power BI and SQL, along with automation in testing workflows, positions Sebia as a provider of modern, efficient diagnostic systems that appeal to high-volume laboratories seeking streamlined solutions.

Financial Growth Potential With revenues estimated between 50 and 100 million dollars and ongoing product innovations, Sebia offers significant expansion potential, making it a promising target for new partnerships, distribution channels, and investment opportunities.

Similar companies to Sebia

Sebia Tech Stack

Sebia uses 8 technology products and services including Power BI, OneTrust, SQL, and more. Explore Sebia's tech stack below.

Power BI
Business Intelligence
OneTrust
Cookie Compliance
SQL
Database
Underscore.js
Javascript Libraries
HubSpot
Marketing Automation
Office 365
Office Suites
PHP
Programming Languages
X-XSS-Protection
Security

Media & News

Sebia's Email Address Formats

Sebia uses at least 2 format(s):

Sebia Email Formats	Example	Percentage
First.Last@sebia-usa.com	John.Doe@sebia-usa.com	94%
FLast@sebia-usa.com	JDoe@sebia-usa.com	2%
F.Last@sebia-usa.com	J.Doe@sebia-usa.com	2%
First.Middle@sebia-usa.com	John.Michael@sebia-usa.com	1%
Last@sebia-usa.com	Doe@sebia-usa.com	1%
FLast@sebia.com	JDoe@sebia.com	81%
FirstLast@sebia.com	JohnDoe@sebia.com	10%
First.Last@sebia.com	John.Doe@sebia.com	7%
Last@sebia.com	Doe@sebia.com	2%

Frequently Asked Questions

What is Sebia's phone number?

You can contact Sebia's main corporate office by phone at

+33-1-69-89-8****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sebia's official website and social media links?

Sebia's official website is sebia.com and has social profiles on LinkedIn.

What is Sebia's SIC code NAICS code?

Sebia's SIC code is 8071 - Medical Laboratories NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Sebia have currently?

As of December 2025, Sebia has approximately 1K employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Cto | Chief Technology Officer: A. L.Chief Information Officer, Group / International: R. C.Chief Scientific Officer: P. S.. Explore Sebia's employee directory with LeadIQ.

What industry does Sebia belong to?

Sebia operates in the Medical Equipment Manufacturing industry.

What technology does Sebia use?

Sebia's tech stack includes Power BIOneTrustSQLUnderscore.jsHubSpotOffice 365PHPX-XSS-Protection.

What is Sebia's email format?

Sebia's email format typically follows the pattern of First.Last@sebia-usa.com. Find more Sebia email formats with LeadIQ.

When was Sebia founded?

Sebia was founded in 1967.

Sebia

Q: What is Sebia's official website and social media links?

Sebia's official website is sebia.com. Sebia has social profiles on LinkedIn.

Q: How many employees does Sebia have currently?

Sebia has approximately 1K employees.

Q: What technology does Sebia use?

Sebia's tech stack includes Blazor, C#, Atlassian, Atlassian Jira, Microsoft.

Medical Equipment ManufacturingÎle-de-france, France1001-5000 Employees

Founded in 1967, Sebia is a Global specialty In Vitro Diagnostic leader for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy, Autoimmunity and other rare pathologies.

Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable and interpretable language.

We call it our new language of life. 

Headquartered in the South of Paris (Lisses, France), We set high standards in making continuous advances in technologies, scientific excellence and manufacturing capabilities, providing Sebia the possibility to pursue diagnostic solutions with an exciting pipeline of new tests and automated equipment.